MINAPHARM Pharmaceuticals (EGX:MIPH)

MINAPHARM Pharmaceuticals Revenue

MINAPHARM Pharmaceuticals had revenue of 1.61B EGP in the quarter ending March 31, 2025, with 63.27% growth. This brings the company's revenue in the last twelve months to 6.29B, up 61.05% year-over-year. In the year 2024, MINAPHARM Pharmaceuticals had annual revenue of 5.66B with 45.55% growth.

• Revenue (ttm): 6.29B
• Revenue Growth: +61.05%
• P/S Ratio: 0.44
• Revenue / Employee: 13.97M
• Employees: 450
• Market Cap: 2.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.66B	1.77B	45.55%
Dec 31, 2023	3.89B	271.51M	7.50%
Dec 31, 2022	3.62B	615.19M	20.47%
Dec 31, 2021	3.01B	644.34M	27.29%
Dec 31, 2020	2.36B	309.95M	15.11%